ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy.

A radiotherapy treatment plan for Accuray’s Tomotherapy system to kill white blood cells prior to a liver cancer patient undergoing a transplant. The treatment is aimed at the bone marrow and spares dose to most of the organs to reduce side effects. This was an example plan created on the new Volvo Ultra treatment planning system. The software allow planning for more than 100 cm of anatomy. It also allows users to drag target dose values of the main graph and the system will recalculate all the doses.

Gallery | ASTRO | By Dave Fornell, ITN Editor

Photo Gallery of Technologies at ASTRO 2021

This is an image gallery of technologies on display on the expo floor at the 2021 American Society of Radiation Oncology ...

November 08, 2021

recent research on personalized treatment for HPV-associated oropharyngeal cancer – particularly for patients with an inherited variant KRAS gene

News | Radiation Oncology

Identifying Unique Genetic Variants to Overcome Cancer Treatment Barriers

November 5, 2021 — Robert Chin, M.D., Ph.D., a radiation oncologist with UCLA Jonsson Comprehensive Cancer Center, will ...

November 05, 2021

The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura Dawson, MD, FASTRO, Chair of the ASTRO Board of Directors, in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare and Medicaid Services (CMS)

News | Radiation Oncology

ASTRO Deeply Concerned and Disappointed Over CMS 2022 Final Rules

November 3, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura ...

November 03, 2021

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Radiology Business | Melinda Taschetta-Millane

November 2, 2021 — Here is a list of the Top 10 most popular pieces of content on ITNonline.com from the month of ...

November 02, 2021

FLASH therapy, powered by the use of Varian’s ProBeam, is an experimental treatment modality delivering radiation therapy at ultra-high dose rates, in typically less than one second.

News | Proton Therapy

Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01

November 2, 2021 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center ...

November 02, 2021

Philips will demonstrate its Multimodality RT Simulation Workspace, a precision medicine application that provides a vendor-agnostic single space for simulation, multimodality image fusion and contouring

News | ASTRO

Philips Highlights New Patient-centered Innovations at ASTRO 2021

November 2, 2021 — Philips announced new innovations that can help improve cancer care across the patient journey at the ...

November 02, 2021

Data presented demonstrates use of DCISionRT and its response subtype (Rst) was able to identify women with ductal carcinoma in situ (DCIS) (Stage 0 breast cancer) who remain at an elevated risk of recurrence despite receiving breast conserving surgery (BCS) and radiation therapy (RT).

News | Radiation Therapy

PreludeDx Presents DCIS Precision Medicine Study Results at ASTRO 2021 Annual Meeting

November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast ...

November 02, 2021

News | Stereotactic Body Radiation Therapy (SBRT)

Serial Radiation Therapy is Safe and Effective as Alternative Treatment to Systemic Therapy for Kidney Cancer

October 29, 2021 — In a new single-arm study, researchers at The University of Texas MD Anderson Cancer Center reported ...

October 29, 2021

Elekta Harmony radiation therapy system at ASTRO 2021.

360 Photos | Radiation Therapy

360 Degree View of the Harmony Radiation Therapy System at ASTRO 2021

This is a virtual tour of the New Elekta Harmony radiation therapy system at the American Society of Radiation Oncology ...

October 28, 2021

In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.

News | Radiation Therapy

Optimizing Preoperative Radiation Therapy in High-risk Sarcoma

October 28, 2021 — In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found ...

October 28, 2021

An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides strong evidence for the addition of androgen deprivation therapy (ADT) to definitive radiotherapy (RT) for the treatment of prostate cancer, with the projection that adding ADT to the treatment of 10-15 men would prevent the development of distant metastasis in one man.

News | Prostate Cancer

International Meta-analysis Quantifies Impact of Three Prostate Cancer Therapy Intensification Strategies

October 28, 2021 — An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides ...

October 28, 2021

ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world's largest radiation oncology society, held October 24-27, 2021 in Chicago.

News | Stereotactic Body Radiation Therapy (SBRT)

New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients

October 28, 2021 — ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer ...

October 28, 2021

Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment.

News | Treatment Planning

Prevencio and Memorial Sloan Kettering Cancer Center Data Demonstrates Significant Correlation of AI-driven HART CVE Blood Test Scores with Development of Adverse Heart Events Following Cancer Radiation Treatment

October 27, 2021 — Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE ...

October 27, 2021

Analysis finds that insurance approval processes create substantial time and cost burdens despite most treatments being delivered as originally prescribed

News | ASTRO

New Study Estimates Prior Authorization Costs Radiation Oncology Clinics More Than $40M Each Year

October 27, 2021 — The time required to secure prior authorization approvals for radiation therapy treatments equates to ...

October 27, 2021

A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer.

News | Radiation Oncology

Intervention Eliminates Black-white Gaps in Survival from Early-stage Breast and Lung Cancer

October 25, 2021 — A new study shows that system-level changes to the way cancer care is delivered can also eliminate ...

October 25, 2021

A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.

News | Prostate Cancer

Genetic Biomarker Test Predicts Recurrence and Survival Outcomes for Men with High-risk Prostate Cancer

October 25, 2021 — A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk ...

October 25, 2021

Using fewer—but higher—doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows.

News | Prostate Cancer

Shortened Course of Radiation Therapy Offers Similar Long-term Side Effects Following Prostate Removal Surgery

October 25, 2021 — Using fewer—but higher—doses of radiation to treat men with prostate cancer who had their prostates ...

October 25, 2021

High-dose radiation therapy can be used to lengthen progression-free survival for people with advanced lung cancer when systemic therapy has not fully halted the growth or spread of metastases, according to a new study.

News | Stereotactic Body Radiation Therapy (SBRT)

High-dose Radiation Thwarts Tumor Growth in Patients with Advanced Lung Cancer

October 24, 2021 — High-dose radiation therapy can be used to lengthen progression-free survival for people with ...

October 24, 2021

People with liver cancer awaiting transplantation could benefit from non-invasive radiation treatments but are rarely given this therapy, according to a new analysis of U.S. national data

News | Radiation Therapy

External-beam Radiation Therapy Underused for People with Liver Cancer Awaiting Transplant

October 24, 2021 — People with liver cancer awaiting transplantation could benefit from non-invasive radiation ...

October 24, 2021

Blue Wolf Capital Partners LLC, a New York-based private equity firm, today announced it has entered into an agreement to acquire CIVCO Radiotherapy, a global leader of radiotherapy patient positioning and immobilization equipment, from Roper Technologies, Inc.

News | Radiology Business

Blue Wolf Capital to Acquire CIVCO Radiotherapy from Roper Technologies

October 22, 2021 — Blue Wolf Capital Partners LLC, a New York-based private equity firm, today announced it has entered ...

October 22, 2021